Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aromatase inhibitors and arthralgia.

Literature DB >> 11352973

Aromatase inhibitors and arthralgia.

P P Donnellan, S L Douglas, D A Cameron, R C Leonard.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2001 PMID： 11352973

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

28 in total

1. Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study.

Authors: Ora Singer; Tessa Cigler; Anne B Moore; Alana B Levine; Keith Hentel; Lily Belfi; Huong T Do; Lisa A Mandl
Journal: Arthritis Care Res (Hoboken) Date: 2012-12 Impact factor: 4.794

2. High prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer.

Authors: Nicola Napoli; Swapna Vattikuti; Cynthia Ma; Antonella Rastelli; Anitha Rayani; Ravi Donepudi; Mohammadreza Asadfard; Jayasree Yarramaneni; Matthew Ellis; Reina Armamento-Villareal
Journal: Breast J Date: 2010 Nov-Dec Impact factor: 2.431

3. Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment?

Authors: Elizabeth Cathcart-Rake; Deanne Smith; David Zahrieh; Aminah Jatoi; Ping Yang; Charles L Loprinzi
Journal: Support Care Cancer Date: 2018-05-24 Impact factor: 3.603

4. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.

Authors: Liana D Castel; Katherine E Hartmann; Ingrid A Mayer; Benjamin R Saville; JoAnn Alvarez; Chad S Boomershine; Vandana G Abramson; A Bapsi Chakravarthy; Debra L Friedman; David F Cella
Journal: Cancer Date: 2013-04-10 Impact factor: 6.860

5. Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapy.

Authors: Rebecca A Shelby; Sara N Edmond; Anava A Wren; Francis J Keefe; Jeffrey M Peppercorn; Paul K Marcom; Kimberly L Blackwell; Gretchen G Kimmick
Journal: Support Care Cancer Date: 2014-05-13 Impact factor: 3.603

Aromatase inhibitors and arthralgia.

1. Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study.

2. High prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer.

3. Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment?

4. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.

5. Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapy.

6. Online discussion of drug side effects and discontinuation among breast cancer survivors.

7. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.

Review 8. The expanding use of third-generation aromatase inhibitors: what the general internist needs to know.

9. Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.

10. Musculoskeletal adverse events associated with adjuvant aromatase inhibitors.